BUSINESS PROFILE :
Aurobindo Pharma is a fast track integrated pharmaceutical company, headquartered in Hyderabad, India, producing and marketing active pharmaceutical ingredients (bulk actives), intermediates and speciality generic formulations.
It ranks among the top 5 pharma companies in India and is a multi product, multi technology, transnational company. The company`s products serve consumers in India and over 100 other countries.
Aurobindo Pharma is an R&D driven chemistry business house, with a very broad product portfolio. The company has a presence in fast growing life style disease drugs, anti infective drugs and key speciality therapeutics.
The company is a known leader in the semi synthetic penicillin and cephalosporin. After creating a name for it in producing APIs and intermediates, the company sees major growth in its speciality generic formulations business.
The company sees its potential both in regulated and other global markets. In regulated markets, Aurobindo Pharma visualises profits aided by the thrust in building intellectual property. In the large growth segments of other global markets, it will succeed by virtue of its cost efficient production.
Financials
The company reported 2.29 times jump in net profit to Rs 601.20 million for the quarter ended December 2006, as compared to Rs 261.90 million for the same period in the previous year.
The net sales for the quarter rose 29.19% to Rs 5,284 million, as compared to Rs 4090.2 million, a year ago. The total income in the quarter jumped 33.04% to Rs 5547.3 million, as compared to Rs 4,169.7 million, a year ago.
Operating margins increased to 11.77% during the quarter, a rise of 82.93 basis points, as compared with the corresponding quarter. Net margins, on the other hand, rose from 6.28% to 10.84% during the quarter.
|
